|
2026
|
P/S
|
Antifungal pharmaceutical preparations; Antiviral pharmaceutical preparations; Anti-inflammatory ... |
|
|
P/S
|
Human vaccine preparations; human vaccines |
|
|
P/S
|
Pharmaceutical research and development; Medical and scientific research in the field of cardiome... |
|
|
P/S
|
Pharmaceutical preparations; vaccines for human use. Providing medical information services relat... |
|
|
P/S
|
Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, endocrine, gastroint... |
|
|
P/S
|
Pharmaceutical preparations. |
|
|
P/S
|
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic ... |
|
|
P/S
|
Providing medical information from a web site; Providing medical information in the field of Lyme... |
|
|
P/S
|
Pharmaceuticals, namely, anti-infectives; Medicated dermatological preparations and substances; ... |
|
|
P/S
|
Pharmaceutical preparations for the treatment of dermatological, immunological, inflammatory, res... |
|
|
P/S
|
Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous syst... |
|
2025
|
Invention
|
Heteroaromatic compounds and their use as dopamine d1 ligands.
The present invention provides, i... |
|
|
Invention
|
Combination of a pd-1 antagonist and a vegfr inhibitor for treating cancer.
The present disclosu... |
|
|
Invention
|
Methods and compositions for cancer treatment.
The present application provides methods of treat... |
|
|
P/S
|
Pharmaceutical preparations and substances; Medicinal preparations and substances; Vaccines. |
|
|
Invention
|
Immunogenic compositions and uses thereof.
The invention relates to immunogenic compositions com... |
|
|
P/S
|
Pharmaceutical preparations for the treatment of vaso-occlusive crisis;; Pharmaceutical preparati... |
|
|
P/S
|
Pharmaceutical preparations for the treatment of blood disorders, bone growth disorders, hormonal... |
|
|
P/S
|
Pharmaceutical preparations for the treatment of blood disorders; Pharmaceutical preparations for... |
|
|
Invention
|
Anti-tl1a antibody therapeutic methods.
The present disclosure provides methods and compositions... |
|
|
Invention
|
Lipidated tlr7/8 modulators as adjuvants and uses thereof.
The disclosure relates to compounds o... |
|
|
Invention
|
Lipidated tlr7/8 modulators as adjuvants and uses thereof. The disclosure relates to compounds of... |
|
|
Invention
|
Compounds. The present invention relates to novel compounds and pharmaceutical compositions. More... |
|
|
Invention
|
Substituted fused heteroaryl lactam compounds. The present disclosure relates to fused heteroaryl... |
|
|
Invention
|
Heterocyclic derivatives as glucose-dependent insulinotropic polypeptide receptor antagonists. De... |
|
|
Invention
|
Heterocyclic compounds as glucose-dependent insulinotropic polypeptide receptor antagonists. Desc... |
|
|
Invention
|
Heterocyclic derivatives as glucose-dependent insulinotropic polypeptide receptor antagonists and... |
|
|
Invention
|
Glucose-dependent insulinotropic polypeptide receptor antagonists and uses thereof. Described her... |
|
|
Invention
|
D]pyrimidine compounds. The present invention relates to solid forms, salts, and deuterated analo... |
|
|
Invention
|
Extended release formulations comprising substituted indazole propionic acid derivative compounds... |
|
|
Invention
|
Methods for treatment of atopic dermatitis with an anti-tl1a antibody. The present disclosure pro... |
|
|
Invention
|
Methods for treatment of metabolic dysfunction-associated steatohepatitis with an anti-tl1a antib... |
|
|
Invention
|
Compositions and methods for reduction of double-stranded rna. Described herein are methods and c... |
|
|
Invention
|
Sirp alpha fusion protein formulation. The present invention relates to the field of pharmaceutic... |
|
|
Invention
|
Process to prepare avibactam tomilopil. The present invention is directed to improved processes f... |
|
|
Invention
|
Hybrid sensor network in autoclaving of pre-filled vials.
Method and system of packaging a pre-f... |
|
|
Invention
|
Sars-cov-2 immunogenic compositions. Disclosed herein are compositions comprising protein antigen... |
|
|
Invention
|
Administration of cyp3a inhibitors in the treatment of cancer. The invention relates to methods f... |
|
|
Invention
|
Glucose-dependent insulinotropic polypeptide receptor antagonists and uses thereof.
Described he... |
|
|
Invention
|
4-{4-[(1-{[4-(propan-2-yl)phenyl]carbamoyl)-d-prolyl)amino]cyclohexyl}benzoic acid derivatives as... |
|
|
Invention
|
Immunogenic compositions and uses thereof. The present disclosure relates to compositions compris... |
|
|
Invention
|
Substituted pyridine compounds. The invention relates to compounds of Formula (I), or pharmaceuti... |
|
|
Invention
|
Health information network wellness platform.
A system and method for personalizing health infor... |
|
|
Invention
|
Health information network wellness platform. A system and method for personalizing health inform... |
|
|
Invention
|
Heterocyclic glp-1r modulators. The present disclosure relates to compounds of formula I and phar... |
|
|
Invention
|
Biphenyl and phenylpyridine compounds.
The invention relates to compounds of Formula (I):
The ... |
|
|
Invention
|
Rna molecules. The present disclosure relates to RNA molecules encoding an EBV polypeptide. The p... |
|
|
Invention
|
Neisseria meningitidis compositions and methods thereof.
In one aspect, the disclosure relates t... |
|
|
Invention
|
E. coli fimh mutants and uses thereof.
This disclosure relates to the design of E. coli mutated ... |
|
|
Invention
|
Benzisoxazole sulfonamide derivatives.
The present invention relates to compounds of formula (I)... |
|
|
Invention
|
Solid state forms of (s)-2-(((s)-6,8-difluoro-1,2,3,4-tetrahydronaphthalen-2-yl)amino)-n-(1-(2-me... |
|
|
Invention
|
Polynucleotide compositions and uses thereof.
The invention relates to polypeptides and RNA mole... |
|
|
Invention
|
Immunogenic compositions comprising conjugated capsular saccharide antigens, kits comprising the ... |
|
2024
|
Invention
|
Varenicline formulations.
In an embodiment, there is provided a varenicline formulation consisti... |
|
2023
|
Invention
|
Substituted 1h-pyrazolo-pyridine and -pyrimidine compounds.
This disclosure relates to compounds... |
|
|
Invention
|
Combination of talazoparib and enzalutamide in the treatment of metastatic castration-resistant p... |
|
|
Invention
|
Immunogenic compositions comprising an rsv f protein trimer.
The invention relates to aqueous an... |
|
|
Invention
|
Computerized decision tool for sars-cov-2 variants prediction.
Technology is disclosed for a met... |
